Peng Hsiao

898 total citations
12 papers, 698 citations indexed

About

Peng Hsiao is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Peng Hsiao has authored 12 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Psychiatry and Mental health. Recurrent topics in Peng Hsiao's work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Epilepsy research and treatment (5 papers). Peng Hsiao is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Epilepsy research and treatment (5 papers). Peng Hsiao collaborates with scholars based in United States, Norway and Sweden. Peng Hsiao's co-authors include Jashvant D. Unadkat, Sara Eyal, Christopher J. Endres, Jeanne M. Link, David A. Mankoff, Anand K. Deo, Ann C. Collier, Karen B. Domino, Janet F. Eary and Finbarr O’Sullivan and has published in prestigious journals such as Biochemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Peng Hsiao

12 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Hsiao United States 11 465 316 127 111 98 12 698
Eike Schroeder Germany 7 598 1.3× 391 1.2× 98 0.8× 125 1.1× 107 1.1× 8 825
Jean‐Michel Scherrmann France 16 387 0.8× 209 0.7× 339 2.7× 93 0.8× 47 0.5× 27 968
Birgitta Noé Germany 8 574 1.2× 302 1.0× 213 1.7× 97 0.9× 30 0.3× 8 827
Kimio Tohyama Japan 14 275 0.6× 146 0.5× 195 1.5× 63 0.6× 24 0.2× 36 709
Matthew R. Durk United States 13 254 0.5× 163 0.5× 150 1.2× 105 0.9× 21 0.2× 28 691
Atsushi Ose Japan 10 346 0.7× 182 0.6× 128 1.0× 129 1.2× 24 0.2× 18 601
Rong Zhao China 9 204 0.4× 120 0.4× 79 0.6× 68 0.6× 32 0.3× 16 400
Ralph E. Davidson United States 6 391 0.8× 218 0.7× 204 1.6× 124 1.1× 49 0.5× 6 649
Naoki Ishiguro Japan 13 445 1.0× 218 0.7× 202 1.6× 316 2.8× 17 0.2× 32 878
David Dickens United Kingdom 14 192 0.4× 106 0.3× 185 1.5× 27 0.2× 59 0.6× 19 507

Countries citing papers authored by Peng Hsiao

Since Specialization
Citations

This map shows the geographic impact of Peng Hsiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Hsiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Hsiao more than expected).

Fields of papers citing papers by Peng Hsiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Hsiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Hsiao. The network helps show where Peng Hsiao may publish in the future.

Co-authorship network of co-authors of Peng Hsiao

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Hsiao. A scholar is included among the top collaborators of Peng Hsiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Hsiao. Peng Hsiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Shih, Amy Y., Romeo Papazyan, Peng Hsiao, et al.. (2023). pH Dependence of a GPR4 Selective Antagonist Hampers Its Therapeutic Potential. Journal of Pharmacology and Experimental Therapeutics. 386(1). 35–44. 5 indexed citations
2.
Parker, Mackenzie J., Hyelee Lee, Shihua Yao, et al.. (2023). Identification of 2-Sulfonyl/Sulfonamide Pyrimidines as Covalent Inhibitors of WRN Using a Multiplexed High-Throughput Screening Assay. Biochemistry. 62(14). 2147–2160. 16 indexed citations
3.
Liu, Li, Ann C. Collier, Jeanne M. Link, et al.. (2015). Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study. Drug Metabolism and Disposition. 43(11). 1795–1804. 36 indexed citations
4.
Deo, Anand K., Soo Borson, Jeanne M. Link, et al.. (2014). Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease. Journal of Nuclear Medicine. 55(7). 1106–1111. 155 indexed citations
5.
Lai, Yurong & Peng Hsiao. (2014). Beyond the ITC White Paper: Emerging Sciences in Drug Transporters and Opportunities for Drug Development. Current Pharmaceutical Design. 20(10). 1577–1594. 11 indexed citations
6.
Hsiao, Peng & Jashvant D. Unadkat. (2013). Predicting the Outer Boundaries of P-glycoprotein (P-gp)-Based Drug Interactions at the Human Blood–Brain Barrier Based on Rat Studies. Molecular Pharmaceutics. 11(2). 436–444. 14 indexed citations
7.
Hsiao, Peng & Jashvant D. Unadkat. (2012). P-Glycoprotein-Based Loperamide–Cyclosporine Drug Interaction at the Rat Blood–Brain Barrier: Prediction fromIn VitroStudies and Extrapolation to Humans. Molecular Pharmaceutics. 9(3). 629–633. 21 indexed citations
8.
Eyal, Sara, Mark Muzi, J. M. Link, et al.. (2009). Positron emission tomography imaging of tissue P‐glycoprotein activity during pregnancy in the non‐human primate. British Journal of Pharmacology. 159(2). 394–404. 26 indexed citations
9.
Eyal, Sara, Peng Hsiao, & Jashvant D. Unadkat. (2009). Drug interactions at the blood-brain barrier: Fact or fantasy?☆. Pharmacology & Therapeutics. 123(1). 80–104. 149 indexed citations
10.
Hsiao, Peng, Tot Bui, Rodney J. Y. Ho, & Jashvant D. Unadkat. (2007). In Vitro-to-in Vivo Prediction of P-glycoprotein-Based Drug Interactions at the Human and Rodent Blood-Brain Barrier. Drug Metabolism and Disposition. 36(3). 481–484. 53 indexed citations
11.
Hsiao, Peng, Lucy Sasongko, Jeanne M. Link, et al.. (2006). Verapamil P-glycoprotein Transport across the Rat Blood-Brain Barrier: Cyclosporine, a Concentration Inhibition Analysis, and Comparison with Human Data. Journal of Pharmacology and Experimental Therapeutics. 317(2). 704–710. 77 indexed citations
12.
Endres, Christopher J., et al.. (2005). The role of transporters in drug interactions. European Journal of Pharmaceutical Sciences. 27(5). 501–517. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026